Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

Background To ensure the highest quality of human papillomavirus (HPV) testing in primary cervical cancer screening, novel HPV assays must be evaluated in accordance with the international guidelines. Furthermore, HPV assay with genotyping capabilities are becoming increasingly important in triage o...

Full description

Saved in:
Bibliographic Details
Published in:BMC cancer Vol. 20; no. 1; pp. 396 - 13
Main Authors: Ejegod, Ditte Møller, Lagheden, Camilla, Bhatia, Ramya, Pedersen, Helle, Boada, Elia Alcañiz, Sundström, Karin, Cortés, Javier, Josë, F. Xavier Bosch, Cuschieri, Kate, Dillner, Joakim, Bonde, Jesper
Format: Journal Article
Language:English
Published: London BioMed Central 06.05.2020
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1471-2407, 1471-2407
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first